Kumar, Vidya P.
Holmes-Hampton, Gregory P.
Biswas, Shukla
Stone, Sasha
Sharma, Neel Kamal
Hritzo, Bernadette
Guilfoyle, Mary
Eichenbaum, Gary
Guha, Chandan
Ghosh, Sanchita P.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (AA112044-001-04000)
JPC-7 (DM178020)
Armed Forces Radiobiology Research Institute, Uniformed Services University (RAB23338)
Article History
Received: 2 December 2021
Accepted: 11 February 2022
First Online: 3 March 2022
Competing interests
: The following authors (VPK, GPHH, SS, SB, NKS, BH, CG and SPG) declare no conflict of interest. MG and GE are employees of Johnson & Johnson and its subsidiary Janssen Pharmaceuticals is working on the development of JNJ-26366821 and stand to benefit financially from the successful development of the compound.